A new topical antibiotic formulation, known as TETRA-ABC kills the most drug-resistant and the most deadly bacteria (Staph, MRSA and Acinetobacter), which cause community or hospital acquired infections. Samples available for evaluation by physicians, hospitals and pharmaceutical companies.